Literature DB >> 5447800

The pharmacology of penfluridol (R 16341) a new potent and orally long-acting neuroleptic drug.

P A Janssen, C J Niemegeers, K H Schellekens, F M Lenaerts, F J Verbruggen, J M Van Nueten, W K Schaper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5447800     DOI： 10.1016/0014-2999(70)90043-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  14 in total

1.  Antagonism by d-amphetamine of learning deficits in rats induced by exposure to antipsychotic drugs during early postnatal life.

Authors:  S Ahlenius; J Engel; P Lundborg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

2.  Learning deficits in 4 weeks old offspring of the nursing mothers treated with the neuroleptic drug penfluridol.

Authors:  S Ahlenius; R Brown; J Engel; P Lundborg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

3.  Regional changes in monoamine levels and in the rate of tyrosine and tryptophan hydroxylation in 4 week old offspring of nursing mothers treated with the neuroleptic drug penfluridol.

Authors:  J Engel; P Lundborg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

Review 4.  Chlorpromazine versus penfluridol for schizophrenia.

Authors:  Naemeh Nikvarz; Mostafa Vahedian; Navid Khalili
Journal:  Cochrane Database Syst Rev       Date:  2017-09-23

5.  Penfluridol: an open phase III study in acute newly admitted hospitalized schizophrenic patients.

Authors:  B Shopsin; H Klein; L Gerbino; G Selzer
Journal:  Psychopharmacology (Berl)       Date:  1977-12-19       Impact factor: 4.530

6.  Long-term behavioural and biochemical effects following prolonged treatment with a neuroleptic drug (flupenthixol) in rats.

Authors:  E B Nielsen
Journal:  Psychopharmacology (Berl)       Date:  1977-10-20       Impact factor: 4.530

7.  A preliminary study of sex-related differences in prolactin responses to dopamine blockade and insulin hypoglycemia and in penfluridol plasma levels in schizophrenic patients.

Authors:  R S Nathan; E J Sachar; L Ostrow; G M Asnis; U Halbreich; F Halpern; N L Renzi; V Slotnick
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

8.  Online structure-based screening of purchasable approved drugs and natural compounds: retrospective examples of drug repositioning on cancer targets.

Authors:  Nathalie Lagarde; Julien Rey; Aram Gyulkhandanyan; Pierre Tufféry; Maria A Miteva; Bruno O Villoutreix
Journal:  Oncotarget       Date:  2018-08-17

9.  Synthesis and biological evaluation of pyrrolidine-based T-type calcium channel inhibitors for the treatment of neuropathic pain.

Authors:  Hak Kyun Yang; Woo Seung Son; Keon Seung Lim; Gun Hee Kim; Eun Jeong Lim; Changdev G Gadhe; Jae Yeol Lee; Kyu-Sung Jeong; Sang Min Lim; Ae Nim Pae
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

10.  An FDA-Drug Library Screen for Compounds with Bioactivities against Meticillin-Resistant Staphylococcus aureus (MRSA).

Authors:  Qiu Ying Lau; Yoke Yan Fion Tan; Vanessa Chai Yin Goh; David Jing Qin Lee; Fui Mee Ng; Esther H Q Ong; Jeffrey Hill; Cheng San Brian Chia
Journal:  Antibiotics (Basel)       Date:  2015-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.